Frederick W. Goldberg

1.7k total citations
35 papers, 807 citations indexed

About

Frederick W. Goldberg is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Frederick W. Goldberg has authored 35 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Frederick W. Goldberg's work include Asymmetric Hydrogenation and Catalysis (5 papers), Hormonal Regulation and Hypertension (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Frederick W. Goldberg is often cited by papers focused on Asymmetric Hydrogenation and Catalysis (5 papers), Hormonal Regulation and Hypertension (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Frederick W. Goldberg collaborates with scholars based in United Kingdom, United States and Poland. Frederick W. Goldberg's co-authors include Jason G. Kettle, Matthew W. D. Perry, Thierry Kogej, James S. Scott, Andrew V. Turnbull, Philip Magnus, Jian Xiong, V. Lynch, Gillian M. Lamont and Claire J. Russell and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Frederick W. Goldberg

34 papers receiving 796 citations

Peers

Countries citing papers authored by Frederick W. Goldberg

Since Specialization

Citations

This map shows the geographic impact of Frederick W. Goldberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick W. Goldberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick W. Goldberg more than expected).

Fields of papers citing papers by Frederick W. Goldberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick W. Goldberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick W. Goldberg. The network helps show where Frederick W. Goldberg may publish in the future.

Co-authorship network of co-authors of Frederick W. Goldberg

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick W. Goldberg. A scholar is included among the top collaborators of Frederick W. Goldberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick W. Goldberg. Frederick W. Goldberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	α‐Functionalisation of Cyclic Sulfides Enabled by Lithiation Trapping	Angewandte Chemie	Masakazu Atobe, James D. Firth et al.	0
2	α‐Functionalisation of Cyclic Sulfides Enabled by Lithiation Trapping	Angewandte Chemie International Edition	Masakazu Atobe, James D. Firth et al.	5
3	Chemical Biology Approaches Confirm MCT4 as the Therapeutic Target of a Cellular Optimized Hit	ACS Chemical Biology	Roger Clark, Ronald Tomlinson et al.	8
4	Optimization of hERG and Pharmacokinetic Properties for Basic Dihydro-8H-purin-8-one Inhibitors of DNA-PK	ACS Medicinal Chemistry Letters	Frederick W. Goldberg, Attilla Ting et al.	7
5	Rationale and design of phase 1 FTIH study of FOXP3 antisense oligonucleotide AZD8701 in patients with selected advanced solid tumors.	Journal of Clinical Oncology	Michele Petruzzelli, Sophie Postel‐Vinay et al.	1
6	The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor	Journal of Medicinal Chemistry	Frederick W. Goldberg, M. Raymond V. Finlay et al.	66
7	Abstract 1207: Reversing lactate-driven immunosuppression using the novel, potent and selective MCT4 inhibitor AZD0095	Cancer Research	Susan E. Critchlow, Gareth Hughes et al.	5
8	Preclinical Evaluation of AZ12601011 and AZ12799734, Inhibitors of Transforming Growth Factor β Superfamily Type 1 Receptors	Molecular Pharmacology	Lindsay C. Spender, Gail Ferguson et al.	26
9	Evolution of Small Molecule Kinase Drugs	ACS Medicinal Chemistry Letters	Helen L. Lightfoot, Frederick W. Goldberg et al.	27
10	Optimization of Highly Kinase Selective Bis-anilino Pyrimidine PAK1 Inhibitors	ACS Medicinal Chemistry Letters	William McCoull, Edward J. Hennessy et al.	20
11	Design of pyrazolo-pyrimidines as 11β-HSD1 inhibitors through optimisation of molecular electrostatic potential	MedChemComm	Graeme R. Robb, Scott Boyd et al.	4
12	Designing novel building blocks is an overlooked strategy to improve compound quality	Drug Discovery Today	Frederick W. Goldberg, Jason G. Kettle et al.	158
13	Identification and optimisation of 7-azaindole PAK1 inhibitors with improved potency and kinase selectivity	MedChemComm	William McCoull, Edward J. Hennessy et al.	14
14	Aziridine-based concise synthesis of (±)-alstonerine	Chemical Communications	Donald C. Craig, Frederick W. Goldberg et al.	11
15	Asymmetric synthesis of 2-alkyl-substituted tetrahydroquinolines by an enantioselective aza-Michael reaction	Organic & Biomolecular Chemistry	Frederick W. Goldberg, King Kuok Hii et al.	34
16	Discovery and optimization of efficacious neutral 4-amino-6-biphenyl-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5-one diacylglycerol acyl transferase-1 (DGAT1) inhibitors	MedChemComm	Frederick W. Goldberg, Alan M. Birch et al.	2
17	The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrow	Drug Discovery Today	Klaus Pors, Frederick W. Goldberg et al.	9
18	Rapid Generation of a High Quality Lead for Transforming Growth Factor-β (TGF-β) Type I Receptor (ALK5)	Journal of Medicinal Chemistry	Frederick W. Goldberg, Richard A. Ward et al.	33
19	A Mild Thermal and Acid-Catalyzed Rearrangement of O-Aryl Ethers into ortho-Hydroxy Arenes	Organic Letters	Frederick W. Goldberg, Philip Magnus et al.	31
20	INFLUENCE OF THERMAL CUTTING AND ITS QUALITY ON THE FATIGUE STRENGTH OF STEEL	Welding Journal	Frederick W. Goldberg	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact